Market revenue in 2022 | USD 333.1 million |
Market revenue in 2030 | USD 511.0 million |
Growth rate | 5.5% (CAGR from 2022 to 2030) |
Largest segment | Dietary supplements |
Fastest growing segment | Dietary Supplements |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | OTC pharma products, Dietary Supplements |
Key market players worldwide | Bayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis |
Dietary supplements was the largest segment with a revenue share of 98.11% in 2024. Horizon Databook has segmented the Mexico menopause market based on otc pharma products, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.
Around 31%–50% of postmenopausal women suffer from night sweats and hot flashes in Mexico, which is similar to the scenario in the U.S. The onset of menopause is early, as compared to North American women; although the prevalence of hot flashes is lower due to dietary differences. However, changes in food habits due to westernized diets are expected to increase the demand for dietary supplements for menopausal symptoms in the country over the forecast period.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account